Patient Diversity, Recruitment & Engagement

Global Considerations for Retention Plans & Visit Flexibility Across US, EU and UK

Posted on By digi

Global Considerations for Retention Plans & Visit Flexibility Across US, EU and UK Global Considerations for Retention Plans & Visit Flexibility Across US, EU and UK In the evolving landscape of clinical research, the retention of participants is critical for the success of clinical trials. Regulatory authorities such as the FDA, EMA, and MHRA emphasize…

Read More “Global Considerations for Retention Plans & Visit Flexibility Across US, EU and UK” »

Retention Plans & Visit Flexibility

Budgeting, Contracts and FMV Considerations for Retention Plans & Visit Flexibility

Posted on By digi

Budgeting, Contracts and FMV Considerations for Retention Plans & Visit Flexibility In the burgeoning landscape of clinical trials, the convergence of budget management, contractual obligations, and fair market value (FMV) considerations plays a vital role in ensuring patient retention and visit flexibility. This comprehensive guide aims to equip clinical operations, regulatory affairs, and medical affairs…

Read More “Budgeting, Contracts and FMV Considerations for Retention Plans & Visit Flexibility” »

Retention Plans & Visit Flexibility

Training Study Teams and Vendors to Execute Retention Plans & Visit Flexibility Well

Posted on By digi

Training Study Teams and Vendors to Execute Retention Plans & Visit Flexibility Well Training Study Teams and Vendors to Execute Retention Plans & Visit Flexibility Well Introduction to Retention Strategies in Clinical Trials Retention in clinical trials is critical to ensure that the collected data is of high quality, comprehensive, and reliable. Engaging with participants…

Read More “Training Study Teams and Vendors to Execute Retention Plans & Visit Flexibility Well” »

Retention Plans & Visit Flexibility

Partnering with Sites and Communities to Scale Retention Plans & Visit Flexibility

Posted on By digi

Partnering with Sites and Communities to Scale Retention Plans & Visit Flexibility Partnering with Sites and Communities to Scale Retention Plans & Visit Flexibility In the evolving landscape of oncology clinical research, patient retention remains a critical factor influencing the success of clinical trials. As demands for diverse patient populations surge, clinical trial professionals must…

Read More “Partnering with Sites and Communities to Scale Retention Plans & Visit Flexibility” »

Retention Plans & Visit Flexibility

Aligning Decentralized Approaches for Access With DCT, Hybrid and Traditional Trial Models

Posted on By digi

Aligning Decentralized Approaches for Access With DCT, Hybrid and Traditional Trial Models Aligning Decentralized Approaches for Access With DCT, Hybrid and Traditional Trial Models As the landscape of clinical trials continues to evolve, the integration of decentralized clinical trial (DCT) methodologies represents a significant opportunity to enhance patient access and engagement. This comprehensive guide delineates…

Read More “Aligning Decentralized Approaches for Access With DCT, Hybrid and Traditional Trial Models” »

Decentralized Approaches for Access

Common Pitfalls in Decentralized Approaches for Access—and How to Avoid Slow Enrollment

Posted on By digi

Common Pitfalls in Decentralized Approaches for Access—and How to Avoid Slow Enrollment In recent years, decentralized clinical trials have gained significant traction as a means of increasing patient diversity and streamlining patient enrollment in clinical trials. While these innovative approaches promise improved engagement and accessibility, they also come with unique challenges that can adversely affect…

Read More “Common Pitfalls in Decentralized Approaches for Access—and How to Avoid Slow Enrollment” »

Decentralized Approaches for Access

Decentralized Approaches for Access in Practice: Step-by-Step Guide for Recruitment Leads

Posted on By digi

Decentralized Approaches for Access in Practice: Step-by-Step Guide for Recruitment Leads Introduction to Decentralized Approaches in Clinical Trials The landscape of clinical trials is continuously evolving as researchers and regulatory bodies seek innovative ways to enhance patient diversity and improve recruitment yields. Decentralized clinical trial (DCT) approaches have gained traction in recent years, particularly in…

Read More “Decentralized Approaches for Access in Practice: Step-by-Step Guide for Recruitment Leads” »

Decentralized Approaches for Access

How to Build Decentralized Approaches for Access That Sponsors, Sites and Patients Trust

Posted on By digi

How to Build Decentralized Approaches for Access That Sponsors, Sites and Patients Trust How to Build Decentralized Approaches for Access That Sponsors, Sites and Patients Trust Decentralized clinical trials are rapidly gaining traction as an innovative way to enhance patient accessibility, enrich diversity in clinical trial populations, and ultimately improve patient outcomes. This comprehensive guide…

Read More “How to Build Decentralized Approaches for Access That Sponsors, Sites and Patients Trust” »

Decentralized Approaches for Access

Decentralized Approaches for Access: Playbook for High-Performing Global Clinical Trials

Posted on By digi

Decentralized Approaches for Access: Playbook for High-Performing Global Clinical Trials Decentralized Approaches for Access: Playbook for High-Performing Global Clinical Trials In the evolving landscape of clinical research and trials, decentralized approaches are becoming pivotal in optimizing patient recruitment, enhancing engagement, and improving overall outcomes. This article serves as a comprehensive playbook for clinical operations, regulatory…

Read More “Decentralized Approaches for Access: Playbook for High-Performing Global Clinical Trials” »

Decentralized Approaches for Access

Ethics, Compliance and Privacy Considerations in Decentralized Approaches for Access

Posted on By digi

Ethics, Compliance and Privacy Considerations in Decentralized Approaches for Access Ethics, Compliance and Privacy Considerations in Decentralized Approaches for Access Introduction to Decentralized Clinical Trials The landscape of clinical trials is rapidly evolving, particularly with the increased adoption of decentralized approaches. These strategies offer a novel way to enhance patient access and engagement, especially in…

Read More “Ethics, Compliance and Privacy Considerations in Decentralized Approaches for Access” »

Decentralized Approaches for Access